These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease. Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992 [TBL] [Abstract][Full Text] [Related]
12. Postural visual obscurations in patients with inactive thyroid eye disease; a variant of 'hydraulic' disease. Rose GE Eye (Lond); 2006 Oct; 20(10):1178-85. PubMed ID: 17019416 [TBL] [Abstract][Full Text] [Related]
13. Age differences in clinical manifestation and prognosis of thyroid eye disease. Ben Simon GJ; Katz G; Zloto O; Leiba H; Hadas B; Huna-Baron R Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2301-8. PubMed ID: 26344731 [TBL] [Abstract][Full Text] [Related]
14. Late reactivation of thyroid orbitopathy. Selva D; Chen C; King G Clin Exp Ophthalmol; 2004 Feb; 32(1):46-50. PubMed ID: 14746591 [TBL] [Abstract][Full Text] [Related]
15. Smoking and strabismus surgery in patients with thyroid eye disease. Rajendram R; Bunce C; Adams GG; Dayan CM; Rose GE Ophthalmology; 2011 Dec; 118(12):2493-7. PubMed ID: 21872937 [TBL] [Abstract][Full Text] [Related]
16. A treatment strategy for Graves' orbitopathy. Marcocci C; Pinchera A; Marinò M Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970 [TBL] [Abstract][Full Text] [Related]